In this study, they showed that Jag1 antibody (15D11) targeting both tumor- and osteoblast-derived Jag1 helps sensitize skeletal metastases to chemotherapy in osteoblastic gain of function Jag1 mouse model. This evidence concerns the gene JAG1 and neoplasm.